# Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)

> **NCT04702503** · PHASE1 · COMPLETED · sponsor: **Moleculin Biotech, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Cutaneous T-Cell Lymphoma/Mycosis Fungoides

## Interventions

- **DRUG:** WP1220

## Key facts

- **NCT ID:** NCT04702503
- **Lead sponsor:** Moleculin Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-08
- **Primary completion:** 2019-11-15
- **Final completion:** 2020-11-15
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702503, "Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04702503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*